Summit Therapeutics Inc Net Income per Employee (SMMT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Summit Therapeutics Inc   (NASDAQ: SMMT)
 

Summit Therapeutics Inc Net Income per Employee

SMMT's Quarterly Results, Trends, Rankings, Statistics
Summit Therapeutics Inc recorded a cumulative net loss of $-833 million during 12 month ending in the third quarter 2026.
The Healthcare sector has seen employees of 415 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 4185, from total ranking in previous quarter at 4804.


What is Income per Employee Ratio?






SMMT Net Income per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -3,142,192 -3,230,525 -4,551,309 -4,073,909 -3,477,800
SMMT's Total Ranking # 4185 # 4804 # 4321 # 4374 # 4029
Seq. Net Income Change - - - - -


SMMT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 416
Healthcare Sector # 869
Overall Market # 4185

Net Income per Employee Statistics
High Average Low
$ 28,264 $ -1,049,951 $ -4,551,309
(Dec 31 2019)   (Mar 31 2026)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026


Date modified: 2026-11-05T06:40:52+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.